Previous issues
- Page Path
-
- HOME
- BROWSE ARTICLES
- Previous issue
|
- Guideline
- KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications
- Clin Mol Hepatol. 2020;26(2):83-127. Published online January 10, 2020
- Reviews
- Application of transient elastography in nonalcoholic fatty liver disease
- Xinrong Zhang, Grace Lai-Hung Wong, Vincent Wai-Sun Wong
- Clin Mol Hepatol. 2020;26(2):128-141. Published online November 8, 2019
- Drug induced liver injury: East versus West – a systematic review and meta-analysis
- En Xian Sarah Low, Qishi Zheng, Edwin Chan, Seng Gee Lim
- Clin Mol Hepatol. 2020;26(2):142-154. Published online December 10, 2019
- Switching to systemic therapy after locoregional treatment failure: Definition and best timing
- Sadahisa Ogasawara, Yoshihiko Ooka, Keisuke Koroki, Susumu Maruta, Hiroaki Kanzaki, Kengo Kanayama, Kazufumi Kobayashi, Soichiro Kiyono, Masato Nakamura, Naoya Kanogawa, Tomoko Saito, Takayuki Kondo, Eiichiro Suzuki, Shingo Nakamoto, Akinobu Tawada, Tetsuhiro Chiba, Makoto Arai, Jun Kato, Naoya Kato
- Clin Mol Hepatol. 2020;26(2):155-162. Published online January 15, 2020
- Regulated differentiation of stem cells into an artificial 3D liver as a transplantable source
- Feng Chen, Hua Wang, Jia Xiao
- Clin Mol Hepatol. 2020;26(2):163-179. Published online February 27, 2020
- Editorials
- Should physicians go out of the way to differentiate between acute hepatitis B and acute exacerbation of chronic hepatitis B?
- Hyun Woong Lee
- Clin Mol Hepatol. 2020;26(2):180-182. Published online April 7, 2020
- Should you advocate for hepatocellular carcinoma surveillance in patients with alcohol-related liver disease or non-alcoholic fatty liver disease?
- Ju Hyun Shim
- Clin Mol Hepatol. 2020;26(2):183-184. Published online March 12, 2020
- Toll-like receptor 9, a possible blocker of non-alcoholic steatohepatitis?
- Soung Won Jeong
- Clin Mol Hepatol. 2020;26(2):185-186. Published online March 23, 2020
- Original Articles
- The dilemma of differentiating between acute hepatitis B and chronic hepatitis B with acute exacerbation: Is quantitative serology the answer?
- Sujata Lall, Pragya Agarwala, Guresh Kumar, Manoj Kumar Sharma, Ekta Gupta
- Clin Mol Hepatol. 2020;26(2):187-195. Published online April 7, 2020
- Comparisons between non-alcoholic steatohepatitis and alcohol-related hepatocellular carcinoma
- Rahul Kumar, Boon-Bee George Goh, Jia-Wen Kam, Pik-Eu Chang, Chee-Kiat Tan
- Clin Mol Hepatol. 2020;26(2):196-208. Published online January 9, 2020
- Trends in the prevalence of chronic liver disease in the Korean adult population, 1998–2017
- Seung Ha Park, Lindsay D. Plank, Ki Tae Suk, Yong Eun Park, Jin Lee, Joon Hyuk Choi, Nae Yun Heo, Jongha Park, Tae Oh Kim, Young Soo Moon, Hyun Kuk Kim, Hang Jea Jang, Ha Young Park, Dong Joon Kim
- Clin Mol Hepatol. 2020;26(2):209-215. Published online November 4, 2019
- Limited expression of TLR9 on T cells and its functional consequences in patients with nonalcoholic fatty liver disease
- Nadia Soledad Alegre, Cecilia Claudia Garcia, Luis Ariel Billordo, Beatriz Ameigeiras, Daniel Poncino, Javier Benavides, Luis Colombato, Alejandra Claudia Cherñavsky
- Clin Mol Hepatol. 2020;26(2):216-226. Published online December 5, 2019
- Letters to the Editor
- Multimodal sequential treatment for occluded TIPS: Case report and review of literature
- Nicoletta De Matthaeis, Carmine Di Stasi, Fabrizio Pizzolante, Riccardo Manfredi, Gian Ludovico Rapaccini, Luca Miele
- Clin Mol Hepatol. 2020;26(2):227-230. Published online November 18, 2019
- Fibrolamellar hepatocellular carcinoma-related hyperammonemic encephalopathy: Up to now and next steps
- Rodrigo Cañada Trofo Surjan, Elizabeth Santana dos Santos, Sergio do Prado Silveira, Fabio Ferrari Makdissi, Marcel Autran Cesar Machado
- Clin Mol Hepatol. 2020;26(2):231-232. Published online November 4, 2019
- A challenge in distinguishing between acute hepatitis B and acute exacerbation of chronic hepatitis B
- Yang-Hyun Baek
- Clin Mol Hepatol. 2020;26(2):233-235. Published online April 7, 2020
- Does limited expression of toll-like receptor 9 actually contribute to T cell activation and liver damage in nonalcoholic steatohepatitis?
- Hyuk Soo Eun
- Clin Mol Hepatol. 2020;26(2):236-237. Published online April 7, 2020
- Intricate interpretation of etiology-specific outcome comparison in patients with hepatocellular carcinoma
- Hwi Young Kim, Jean-François Dufour
- Clin Mol Hepatol. 2020;26(2):238-239. Published online March 18, 2020
- Limited expression of toll-like receptor 9 on T cells and its functional consequences in patients with nonalcoholic fatty liver disease
- Jung Hwan Yu
- Clin Mol Hepatol. 2020;26(2):240-241. Published online March 23, 2020
-
Clinical and
Molecular
HepatologyPrint ISSN: 2287-2728
Online ISSN: 2287-285X
-
-
- Immunopathogenesis of liver fibrosis in steatotic liver disease
- Recent updates on pharmacologic therapy in non-alcoholic fatty liver disease
- The role of the hepatic autonomic nervous system
- HBeAg-positive grey-zone patients: Treatment beyond guideline recommendations?
- Systemic therapy in advanced hepatocellular carcinoma
- Epidemiology and updated management for autoimmune liver disease
- Microbiome and metabolomics in alcoholic liver disease
- Personalized medicine in nonalcoholic fatty liver disease
- Acute on chronic liver failure in cirrhosis
- Current status and outcome of liver transplantation in South Korea
- History and future of hepatitis B virus control in South Korea
- Hepatocellular carcinoma statistics in South Korea
Impact Factor8.9First decision
09 Days
Publication after acceptance
04 Days
*Last 12 months
- MOST VIEWED (Last 6 months)
- MOST CITED (2022-2024)
|
|||||||
